MedTrace Logo

A Glucometabolic Evaluation of Patients With Idiopathic Ketotic Hypoglycemia

NCT05310292 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-05-12

No results posted yet for this study

Summary

The project will evaluate 1) the postprandial metabolism and 2) continuous glucose levels in subjects diagnosed with Idiopathic Ketotic Hypoglycemia (IKH)) and healthy control subjects.

Conditions

  • Idiopathic Ketotic Hypoglycemia

Interventions

BIOLOGICAL

Oral glucose tolerance test

Consumption of 75 grams of glucose, diluted in water, added 1,5 g of acetaminophen.

BIOLOGICAL

Mixed meal test

Consumption of a standardized liquid meal, with caloric and dietary content equal to a standard meal.

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2024-04-01
Completion
2025-04-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310292 on ClinicalTrials.gov